Video
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FRQ4C3FBG5B7VJMUWRESYOQFIQ.jpg)
Duración: 02:07
Conoce todos los detalles de la aplicación de la vacuna bivalente contra el COVID-19 en Perú
El proceso de inoculación continúa en el Perú y el Ministerio de Salud anunció la ampliación del rango etario para la aplicación de la vacuna bivalente contra el COVID-19. Conoce todos los detalles en este video.
- Redacción Trome
- 16 de feb. de 2023 10:17 a. m.
- Duración: 02:07
PLAYLIST
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FRQ4C3FBG5B7VJMUWRESYOQFIQ.jpg)
Conoce todos los detalles de la aplicación de la vacuna bivalente contra el COVID-19 en Perú
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/HVNQMGMM2REPNHVNDV6RKPKZVU.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/CHI2LENIVRHR5AWK6LBLQFSWSY.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/CMBK2QNIUFETLHIYCHFBQYAYMA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/4JT57LGN2VAONIETGEZHUVVXHQ.png)
Lo último en Actualidad
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JPNXPXG6RFFHJDFWCZGKEWQ5UI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/K4QG6Y2VANEOHHA5DBTNHUM7LU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/BWcGMXqb/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/V2VKI5CD7BDV3OO3HFAK647FN4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FURYXSN77VB4BKJ6QB6V22W6SM.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/LUVZ2FPKZBCIDANSA4VR5NR7FQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/OTZSRN7QAVGF5INGAO6T3M3JBM.png)
:quality(75)/cdn.jwplayer.com/v2/media/SradLFxH/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/5E25INWYQFDJTL3TATTMOAAYZY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/cubdQWm6/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/KBNBCFNZ5NF7VAGA7EQXKPZ5E4.png)
:quality(75)/cdn.jwplayer.com/v2/media/qtukWL3B/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/6JTKTTCGQ5EMBDWYRML3T7CS5Q.png)
:quality(75)/cdn.jwplayer.com/v2/media/w5scU31w/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/kvGZd60J/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/bpBn5T9P/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/mBBQZQJh/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/B5DG2M7b/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/5ERQOAHLV5CD7GIVGK6BX6KLLE.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6xLhX8bo/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/x1pWv817/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/uLFcFqb5/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/47ZIYR5I3NHYLDYMX6HNEXHQWM.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/IgRLZjzm/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/zTIslyMS/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/XngObz2M/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/3ZAFVDTS7VAGDFMZX27R7HEQNI.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/lMr7Y9LG/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/NXXB4Gle/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/QoxqetyX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/o1asqPX9/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/eyUjAQRO/poster.jpg)